CD8A and Miyoshi myopathy: In most cases, the T cell response of our MM patients was triggered by both CD4+ and CD8+ (48.4%), followed by CD4+ dominated responses (45.2%), while few MM patients (6.4%) showed a response solely mediated by CD8+.